Understanding how mechanical forces affect PD-1 in cancer treatment
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
This study is looking at how physical forces affect a protein called PD-1, which helps control T cells in cancer, and it's designed for people with melanoma to find new ways to improve cancer treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10977517 on NIH RePORTER |
What this research studies
This research investigates the role of mechanical forces on the PD-1 protein, which is crucial in regulating T cell activity and exhaustion in cancer. By using advanced physical science tools and mouse models of melanoma, the team aims to explore how these forces influence PD-1 interactions and signaling pathways. The study employs innovative techniques such as mechanical tension probes and molecular dynamics simulations to gain insights into PD-1's behavior under different conditions. This comprehensive approach could lead to new strategies for enhancing cancer immunotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with melanoma or other cancers that may benefit from enhanced immunotherapy approaches.
Not a fit: Patients with non-cancerous conditions or those not eligible for immunotherapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve cancer immunotherapy by providing new methods to enhance T cell responses against tumors.
How similar studies have performed: While the mechanobiology of PD-1 is a relatively novel area of investigation, previous studies have shown promise in targeting similar pathways for cancer treatment.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Zhu, Cheng — Georgia Institute of Technology
- Study coordinator: Zhu, Cheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.